| 產(chǎn)品編號(hào) | 圖片 | CAS No. | 名稱及描述 | 規(guī)格 | 價(jià)格 | 分子式 | 快速訂購 |
|---|---|---|---|---|---|---|---|
| 137621-100MG |
|
NA |
1-?[(4R)?-?4-?苯基-?4,?5-?二氫-?2-惡唑基]?異喹啉 1-?[(4R)?-?4-?Phenyl-?4,?5-?dihydro-?2-?oxazolyl]?isoquinoline 請(qǐng)咨詢 大賽璐 ≥98%,- |
100MG | 需詢價(jià) | C18H14N2O | |
| 137612-100MG |
|
1402851-52-8 |
1-?[(4S)?-?4-?叔丁基-?4,?5-?二氫-?2-惡唑基]?異喹啉 1-?[(4S)?-?4-?tert-Bu?tyl-?4,?5-?dihydro-?2-?oxazolyl]?isoquinoline 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價(jià) | C16H18N2O | |
| 137611-100MG |
|
1402851-53-9 |
1-?[(4R)?-?4-?叔丁基-?4,?5-?二氫-?2-惡唑基]?異喹啉 1-?[(4R)?-?4-?tert-Bu?tyl-?4,?5-?dihydro-?2-?oxazolyl]?isoquinoline 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價(jià) | C16H18N2O | |
| 137602-100MG |
|
1701405-00-6 |
1-?[(4S)?-?4,?5-?二氫-?4-異丙基-?2-?惡唑基]?異喹啉 1-?[(4S)?-?4,?5-?Dihydro-?4-?isopropyl?-?2-?oxazolyl]?isoquinoline 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價(jià) | C15H16N2O | |
| 137601-100MG |
|
280755-83-1 |
1-?[(4R)?-?4,?5-?二氫-?4-異丙基-?2-?惡唑基]?異喹啉 1-?[(4R)?-?4,?5-?Dihydro-?4-?isopropyl?-?2-?oxazolyl]?isoquinoline 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價(jià) | C15H16N2O | |
| 137262-100MG |
|
1257527-14-2 |
2-[(4S)-4-叔丁基-4,5-二氫-2-惡唑基]-4-三氟甲基吡啶 2-[(4S)-4-tert-Butyl-4,5-dihydro-2-oxazolyl]-4-(trifluoromethyl)pyridine 請(qǐng)咨詢 大賽璐 ≥98%,- |
100MG | 需詢價(jià) | C13H15F3N2O | |
| 137261-100MG |
|
NA |
2-[(4R)-4-叔丁基-4,5-二氫-2-惡唑基]-4-三氟甲基吡啶 2-[(4R)-4-tert-Butyl-4,5-dihydro-2-oxazolyl]-4-(trifluoromethyl)pyridine 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價(jià) | C13H15F3N2O | |
| 135902-100MG |
|
NA |
2-[(4S)-4-異丁基-4,5-二氫-2-惡唑基]-5-三氟甲基吡啶 2-[(4S)-4-Isobutyl-4,5-dihydro-2-oxazolyl]-5-(trifluoromethyl)pyridine 請(qǐng)咨詢 大賽璐 ≥98%,98%e.e. |
100MG | 需詢價(jià) | C13H15F3N2O | |
| 135903-100MG |
|
NA |
2-[(4R)-4-異丁基-4,5-二氫-2-惡唑基]-5-三氟甲基吡啶 2-[(4R)-4-Isobutyl-4,5-dihydro-2-oxazolyl]-5-(trifluoromethyl)pyridine 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價(jià) | C13H15F3N2O | |
| 135887-100MG |
|
NA |
2-[(4S)-4-異丙基-4,5-二氫-2-惡唑基]-5-三氟甲基吡啶 2-[(4S)-4-Isopropyl-4,5-dihydro-2-oxazolyl]-5-(trifluoromethyl)pyridine 請(qǐng)咨詢 大賽璐 ≥98%,98%e.e. |
100MG | 需詢價(jià) | C12H13F3N2O | |
| 135886-100MG |
|
NA |
2-[(4R)-4-異丙基-4,5-二氫-2-惡唑基]-5-三氟甲基吡啶 2-[(4R)-4-Isopropyl-4,5-dihydro-2-oxazolyl]-5-(trifluoromethyl)pyridine 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價(jià) | C12H13F3N2O | |
| 135868-100MG |
|
1416819-91-4 |
2-[(4S)-4-叔丁基-4,5-二氫-2-惡唑基]-5-三氟甲基吡啶 2-[(4S)-4-tert-Butyl-4,5-dihydro-2-oxazolyl]-5-(trifluoromethyl)pyridine 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價(jià) | C13H15F3N2O | |
| 135869-100MG |
|
1428537-19-2 |
2-[(4R)-4-叔丁基-4,5-二氫-2-惡唑基]-5-三氟甲基吡啶 2-[(4R)-4-tert-Butyl-4,5-dihydro-2-oxazolyl]-5-(trifluoromethyl)pyridine 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價(jià) | C13H15F3N2O | |
| 134866-100MG |
|
117408-98-7 |
2-[(4S)-4-叔丁基-4,5-二氫-2-惡唑基]吡啶 2-[(4S)-4-tert-Butyl-4,5-dihydro-2-oxazolyl]pyridine 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價(jià) | C12H16N2O | |
| 134867-100MG |
|
242482-28-6 |
2-[(4R)-4-叔丁基-4,5-二氫-2-惡唑基]吡啶 2-[(4R)-4-tert-Butyl-4,5-dihydro-2-oxazolyl]pyridine 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價(jià) | C12H16N2O | |
| 135094-100MG |
|
108915-04-4 |
2-[(4S)-4,5-二氫-4-異丙基-2-惡唑基]吡啶 2-[(4S)-4,5-Dihydro-4-isopropyl-2-oxazolyl]pyridine 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價(jià) | C11H14N2O | |
| 135095-100MG |
|
132187-16-7 |
2-[(4R)-4,5-二氫-4-異丙基-2-惡唑基]吡啶 2-[(4R)-4,5-Dihydro-4-isopropyl-2-oxazolyl]pyridine 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價(jià) | C11H14N2O | |
| 135092-100MG |
|
108915-08-8 |
2-[(4S)-4,5-二氫-4-(苯基甲基)-2-惡唑基]吡啶 2-[(4S)-4,5-Dihydro-4-(phenylmethyl)-2-oxazolyl]pyridine 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價(jià) | C15H14N2O | |
| 135093-100MG |
|
1108603-35-5 |
2-[(4R)-4,5-二氫-4-(苯基甲基)-2-惡唑基]吡啶 2-[(4R)-4,5-Dihydro-4-(phenylmethyl)-2-oxazolyl]pyridine 請(qǐng)咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價(jià) | C15H14N2O | |
| 135090-100MG |
|
153880-57-0 |
2-[(4S)-4,5-二氫-4-苯基-2-惡唑基]吡啶 2-[(4S)-4,5-Dihydro-4-phenyl-2-oxazolyl]pyridine 請(qǐng)咨詢 大賽璐 ≥95%,98%e.e. |
100MG | 需詢價(jià) | C14H12N2O | |
小泰
|
010-60710855
|